Astra Industrial Group Company (TADAWUL:1212)

Intercept Pharmaceuticals Balance Sheet

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	41.23	178.05	1,058	675.74	46.31	54.46
Short-Term Investments	754.08	667.66	563.18	163	-	-
Cash & Short-Term Investments	795.31	845.7	1,621	838.74	46.31	54.46
Cash Growth	-49.38%	-47.84%	93.30%	1711.00%	-14.96%	20.28%
Accounts Receivable	1,177	1,122	946.94	839.05	769.16	758.75
Other Receivables	34.83	37.5	37.5	66.99	10.39	11.62
Receivables	1,212	1,159	984.44	906.04	779.55	770.36
Inventory	710.63	686.15	715.79	782.63	754.75	743.53
Prepaid Expenses	39.71	35.96	38.35	35.67	30.26	25.8
Restricted Cash	0.14	0.14	0.15	0.02	0.04	3.78
Other Current Assets	79.22	53.67	71.8	95.26	86.68	72.95
Total Current Assets	2,837	2,781	3,432	2,658	1,698	1,671
Property, Plant & Equipment	837.61	818.4	756.22	788.58	1,148	1,189
Long-Term Investments	643.62	646.6	-	-	-	-
Goodwill	32	28.45	28.45	28.45	25.21	25.21
Other Intangible Assets	51.65	47.36	48.26	44.42	10.95	7.22
Long-Term Deferred Tax Assets	3.9	6.16	7.37	5.13	6.17	8.9
Other Long-Term Assets	-	-	-	-	-	0.04
Total Assets	4,405	4,328	4,272	3,525	2,888	2,901
Accounts Payable	285.2	236.37	239.79	242.29	209.56	223.71
Accrued Expenses	462.1	504.72	447.22	315.27	290.54	251.16
Short-Term Debt	358.08	353.27	733.06	417.57	509.6	674.33
Current Portion of Long-Term Debt	43.22	82.22	73.18	4.95	2.76	1.79
Current Portion of Leases	7.48	5.62	5.41	5.95	5.51	5.57
Current Income Taxes Payable	83.31	89.93	69.85	132.18	70.31	74.42
Current Unearned Revenue	134.79	148.19	131.57	159.64	69.06	40.01
Other Current Liabilities	132.07	138.8	129.13	88.41	52.44	47.91
Total Current Liabilities	1,506	1,559	1,829	1,374	1,210	1,319
Long-Term Debt	37.82	39.35	121.68	48.84	7.54	34.58
Long-Term Leases	32.32	35.19	38.04	51.52	33.19	38.04
Long-Term Deferred Tax Liabilities	6.68	6.05	7.02	-	-	-
Total Liabilities	1,749	1,797	2,141	1,612	1,384	1,514
Common Stock	800	800	800	800	800	800
Retained Earnings	1,847	1,745	1,358	1,084	728.29	591.03
Comprehensive Income & Other	-11.42	-21.2	-30.03	-34.16	-76.65	-65.19
Total Common Equity	2,635	2,524	2,128	1,849	1,452	1,326
Minority Interest	21.41	7.16	3.21	63.8	52.45	61.02
Shareholders' Equity	2,657	2,531	2,131	1,913	1,504	1,387
Total Liabilities & Equity	4,405	4,328	4,272	3,525	2,888	2,901
Total Debt	478.92	515.66	971.37	528.82	558.59	754.31
Net Cash (Debt)	316.39	330.05	649.92	309.92	-512.28	-699.85
Net Cash Growth	-38.59%	-49.22%	109.70%	-	-	-
Net Cash Per Share	3.95	4.13	8.12	3.87	-6.40	-8.75
Filing Date Shares Outstanding	80	80	80	80	80	80
Total Common Shares Outstanding	80	80	80	80	80	80
Working Capital	1,330	1,222	1,603	1,284	487.83	351.98
Book Value Per Share	32.94	31.55	26.60	23.12	18.15	16.57
Tangible Book Value	2,552	2,448	2,051	1,777	1,415	1,293
Tangible Book Value Per Share	31.90	30.60	25.64	22.21	17.69	16.17
Land	-	40.4	40.66	606.89	617.12	716.64
Buildings	-	506.91	567.99	-	-	-
Machinery	-	925.91	1,044	1,012	1,236	1,280
Construction In Progress	-	222.73	59.03	72.41	79.11	62.5
Leasehold Improvements	-	27.42	27.63	23.11	23.58	23.53

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.